International Journal of Colorectal Disease

, Volume 23, Issue 7, pp 689–696 | Cite as

Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness

  • Jörg C. Hoffmann
  • Frank Heller
  • Siegbert Faiss
  • Bernd von Lampe
  • Anton J. Kroesen
  • Ulrich Wahnschaffe
  • Jörg-Dieter Schulzke
  • Martin Zeitz
  • Christian Bojarski
Original Article

Abstract

Background/aims

About half of all Crohn’s disease (CD) patients undergo surgery at some point, many because of strictures. An alternative possibility is to dilate strictures endoscopically. However, little is known about prognostic factors.

Patients and methods

Thirty-two patients with primary CD (n = 2), radiogenic strictures (n = 1), or postoperative strictures (27 because of CD; 2 after resection because of cancer), were planned to undergo colonoscopic dilatation of which 25 patients were dilated (10 men; 15 women; median age 48). Length of stenosis, diameter of stricture, balloon size, smoking status, ulcer in the stricture, passage postdilatation, hemoglobin level, complications, redilatation, and subsequent surgery were recorded. Only patients with at least 6 months follow up were included.

Results

Five out of 32 patients had no stenosis, marked inflammation, or fistulas adjacent to the stricture. One patient each had a long stricture (8cm) or a filiform stenosis ruling out dilatation [technical success, 25/27 (92.6%)]. Among these 25 patients, 39 colonoscopies with 51 dilatations were performed. After a single dilatation, 52% were asymptomatic while 48% needed another intervention, half of them surgery. Bleeding without need for transfusion occurred in 3 out of 39 colonoscopies and one perforation required surgery. Significant prognostic factors were smoking and ulcers in the stricture (P < 0.05 each). Some ulcers led to intussusception requiring surgery in spite of good dilatation results.

Conclusion

Through the endoscope balloon stricture dilatation is a relatively safe and often effective treatment modality in ileocolonic strictures. The presence of ulcers in the stricture have a worse outcome as do smokers.

Keywords

Hydrostatic dilation Smoking Crohn’s disease Ulcer Intervention 

References

  1. 1.
    Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15PubMedCrossRefGoogle Scholar
  2. 2.
    Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690–697PubMedCrossRefGoogle Scholar
  3. 3.
    Zankel E, Rogler G, Andus T, Reng CM, Scholmerich J, Timmer A (2005) Crohn’s disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort. Eur J Gastroenterol Hepatol 17:395–401PubMedCrossRefGoogle Scholar
  4. 4.
    Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, Langholz E, Politi P, Qasim A, Koutroubakis I, Tsianos E, Vermeire S, Freitas J, van Zeijl G, Hoie O, Bernklev T, Beltrami M, Rodriguez D, Stockbrugger RW, Moum B (2006) Phenotype at diagnosis predicts recurrence rates in Crohn’s disease. Gut 55:1124–1130PubMedCrossRefGoogle Scholar
  5. 5.
    Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL, Kleibeuker JH (2006) Clinical outcome of Crohn’s disease according to the Vienna classification: disease location is a useful predictor of disease course. Eur J Gastroenterol Hepatol 18:255–261PubMedCrossRefGoogle Scholar
  6. 6.
    Tichansky D, Cagir B, Yoo E, Marcus SM, Fry RD (2000) Strictureplasty for Crohn’s disease: meta-analysis. Dis Colon Rectum 43:911–919PubMedCrossRefGoogle Scholar
  7. 7.
    Roy P, Kumar D (2004) Strictureplasty. Br J Surg 91:1428–1437PubMedCrossRefGoogle Scholar
  8. 8.
    Marchetti F, Fazio VW, Ozuner G (1996) Adenocarcinoma arising from a strictureplasty site in Crohn’s disease. Report of a case. Dis Colon Rectum 39:1315–1321CrossRefGoogle Scholar
  9. 9.
    Blomberg B, Rolny P, Jarnerot G (1991) Endoscopic treatment of anastomotic strictures in Crohn’s disease. Endoscopy 23:195–198PubMedGoogle Scholar
  10. 10.
    Breysem Y, Janssens JF, Coremans G, Vantrappen G, Hendrickx G, Rutgeerts P (1992) Endoscopic balloon dilation of colonic and ileo-colonic Crohn’s strictures: long-term results. Gastrointest Endosc 38:142–147PubMedGoogle Scholar
  11. 11.
    Brooker JC, Beckett CG, Saunders BP, Benson MJ (2003) Long-acting steroid injection after endoscopic dilation of anastomotic Crohn’s strictures may improve the outcome: a retrospective case series. Endoscopy 35:333–337PubMedCrossRefGoogle Scholar
  12. 12.
    Couckuyt H, Gevers AM, Coremans G, Hiele M, Rutgeerts P (1995) Efficacy and safety of hydrostatic balloon dilatation of ileocolonic Crohn’s strictures: a prospective longterm analysis. Gut 36:577–580PubMedCrossRefGoogle Scholar
  13. 13.
    Dear KL, Hunter JO (2001) Colonoscopic hydrostatic balloon dilatation of Crohn’s strictures. J Clin Gastroenterol 33:315–318PubMedCrossRefGoogle Scholar
  14. 14.
    Ferlitsch A, Reinisch W, Puspok A, Dejaco C, Schillinger M, Schofl R, Potzi R, Gangl A, Vogelsang H (2006) Safety and efficacy of endoscopic balloon dilation for treatment of Crohn’s disease strictures. Endoscopy 38:483–487PubMedCrossRefGoogle Scholar
  15. 15.
    Junge U, Zuchner H (1994) Endoscopische Ballondilatation von symptomatischen Strikturen bei Morbus Crohn. Dtsch Med Wochenschr 119:1377–1382PubMedCrossRefGoogle Scholar
  16. 16.
    Lavy A (1997) Triamcinolone improves outcome in Crohn’s disease strictures. Dis Colon Rectum 40:184–186PubMedCrossRefGoogle Scholar
  17. 17.
    Matsui T, Hatakeyama S, Ikeda K, Yao T, Takenaka K, Sakurai T (1997) Long-term outcome of endoscopic balloon dilation in obstructive gastroduodenal Crohn’s disease. Endoscopy 29:640–645PubMedCrossRefGoogle Scholar
  18. 18.
    Morini S, Hassan C, Lorenzetti R, Zullo A, Cerro P, Winn S, Giustini M, Taggi F (2003) Long-term outcome of endoscopic pneumatic dilatation in Crohn’s disease. Dig Liver Dis 35:893–897PubMedCrossRefGoogle Scholar
  19. 19.
    Ramboer C, Verhamme M, Dhondt E, Huys S, Van Eygen K, Vermeire L (1995) Endoscopic treatment of stenosis in recurrent Crohn’s disease with balloon dilation combined with local corticosteroid injection. Gastrointest Endosc 42:252–255PubMedCrossRefGoogle Scholar
  20. 20.
    Sabate JM, Villarejo J, Bouhnik Y, Allez M, Gornet JM, Vahedi K, Modigliani R, Lemann M (2003) Hydrostatic balloon dilatation of Crohn’s strictures. Aliment Pharmacol Ther 18:409–413PubMedCrossRefGoogle Scholar
  21. 21.
    Singh VV, Draganov P, Valentine J (2005) Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease strictures. J Clin Gastroenterol 39:284–290PubMedCrossRefGoogle Scholar
  22. 22.
    Thomas-Gibson S, Brooker JC, Hayward CM, Shah SG, Williams CB, Saunders BP (2003) Colonoscopic balloon dilation of Crohn’s strictures: a review of long-term outcomes. Eur J Gastroenterol Hepatol 15:485–488PubMedCrossRefGoogle Scholar
  23. 23.
    Williams AJ, Palmer KR (1991) Endoscopic balloon dilatation as a therapeutic option in the management of intestinal strictures resulting from Crohn’s disease. Br J Surg 78:453–454PubMedCrossRefGoogle Scholar
  24. 24.
    Bernstein CN, Nabalamba A (2006) Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol 101:110–118PubMedCrossRefGoogle Scholar
  25. 25.
    Greenstein AJ, Sachar DB, Pasternack BS, Janowitz HD (1975) Reoperation and recurrence in Crohn’s colitis and ileocolitis Crude and cumulative rates. N Engl J Med 293:685–690PubMedCrossRefGoogle Scholar
  26. 26.
    Nygaard K, Fausa O (1977) Crohn’s disease. Recurrence after surgical treatment. Scand J Gastroenterol 12:577–584Google Scholar
  27. 27.
    Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G (1984) Natural history of recurrent Crohn’s disease at the ileocolonic anastomosis after curative surgery. Gut 25:665–672PubMedCrossRefGoogle Scholar
  28. 28.
    Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn’s disease. Gastroenterology 99:956–963PubMedGoogle Scholar
  29. 29.
    Cottone M, Rosselli M, Orlando A, Oliva L, Puleo A, Cappello M, Traina M, Tonelli F, Pagliaro L (1994) Smoking habits and recurrence in Crohn’s disease. Gastroenterology 106:643–648PubMedGoogle Scholar
  30. 30.
    Yamamoto T, Keighley MR (2000) Smoking and disease recurrence after operation for Crohn’s disease. Br J Surg 87:398–404PubMedCrossRefGoogle Scholar
  31. 31.
    Olaison G, Smedh K, Sjodahl R (1992) Natural course of Crohn’s disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 33:331–335PubMedCrossRefGoogle Scholar
  32. 32.
    Shore G, Gonzalez QH, Bondora A, Vickers SM (2003) Laparoscopic vs conventional ileocolectomy for primary Crohn disease. Arch Surg 138:76–79PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Jörg C. Hoffmann
    • 1
    • 3
  • Frank Heller
    • 1
  • Siegbert Faiss
    • 1
  • Bernd von Lampe
    • 1
  • Anton J. Kroesen
    • 2
  • Ulrich Wahnschaffe
    • 1
  • Jörg-Dieter Schulzke
    • 1
  • Martin Zeitz
    • 1
  • Christian Bojarski
    • 1
  1. 1.Medizinische Klinik I mit Schwerpunkt GastroenterologieInfektiologie, Rheumatologie, Charité, Campus Benjamin FranklinBerlinGermany
  2. 2.Chirurgische Klinik ICharité, Campus Benjamin FranklinBerlinGermany
  3. 3.Medizinische Klinik I mit Schwerpunkt GastroenterologieDiabetologie, Rheumatologie und Onkologie, St. Marien- und St. AnnastiftskrankenhausLudwigshafenGermany

Personalised recommendations